BioMarin Pharmaceutical Inc. buy Barclays PLC
Start price
04.10.24
/
50%
€62.80
Target price
04.10.25
€78.35
Performance (%)
-24.70%
End price
05.10.25
€47.29
Summary
This prediction ended on 05.10.25 with a price of €47.29. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -24.70%. Barclays_PLC has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.013% | -3.013% | -6.846% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Barclays_PLC for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Barclays PLC from $110.00 to $86.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€68.62
28.10.26
28.10.26
-0.23%
22:25
22:25
Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€47.65
28.01.26
28.01.26
€66.71
28.01.27
28.01.27
-1.80%
22:25
22:25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.46
06.08.24
06.08.24
€100.74
06.08.25
06.08.25
-34.76%
07.08.25
07.08.25